VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $561,216 | -31.7% | 50,697 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $821,798 | +3791.1% | 50,697 | +620.1% | 0.01% | – |
| Q1 2022 | $21,120 | -82.7% | 7,040 | -73.4% | 0.00% | -100.0% |
| Q4 2021 | $121,794 | +29.1% | 26,477 | +76.2% | 0.00% | 0.0% |
| Q3 2021 | $94,344 | -42.8% | 15,023 | -45.4% | 0.00% | -50.0% |
| Q2 2021 | $164,857 | +185.0% | 27,522 | +200.9% | 0.00% | +100.0% |
| Q1 2021 | $57,848 | -65.5% | 9,146 | -69.3% | 0.00% | -50.0% |
| Q4 2020 | $167,853 | +0.8% | 29,814 | +4.2% | 0.00% | 0.0% |
| Q3 2020 | $166,464 | -19.3% | 28,602 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $206,220 | +54.1% | 28,602 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $133,857 | -41.6% | 28,602 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $229,388 | +16.6% | 28,602 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $196,782 | -17.1% | 28,602 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $237,397 | -16.5% | 28,602 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $284,304 | +29.9% | 28,602 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $218,805 | -42.1% | 28,602 | +31.8% | 0.00% | -25.0% |
| Q3 2018 | $377,962 | +83.5% | 21,697 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $206,000 | – | 21,697 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |